AboutCordlife Medical Philippines is a member of the Cordlife Group Limited family of companies. Cordlife Group Limited owns and operates five cord blood laboratories in Singapore, Hong Kong, India, Indonesia and the Philippines.
Labs and LocationsUnit 101, Building H U.P. AyalaLand, TechnoHub Commonwealth Avenue, Diliman Quezon City, Philippines 1101
Business ExperienceCordlife Group Limited is listed on the Mainboard of the Singapore Exchange (SGX), and together with its subsidiaries, may be called "The Group". Cordlife Group Limited owns five cord blood banks in Singapore, Hong Kong, Indonesia, Philippines and India, and has a direct investment in China Cord Blood Corporation, one of the top banks in China. Cordlife also currently owns over 30% of Stemlife Malaysia. At present the laboratories in Singapore, Hong Kong, and India are accredited by AABB (formerly known as American Association of Blood Banks), meeting the gold standard of private cord blood banking. The Group now comprises of:
Cordlife Group Limited - Singapore
Cordlife (Hong Kong) Limited - Hong Kong & Macau
Cordlife Sciences India Pvt Limited - Kolkata, India
PT Cordlife Persada - Jakarta, Indonesia
Cordlife Medical Philippines, Inc. - Manila, Philippines
Cordlife Group Limited was established in Singapore in 2001 to provide a full suite of cord blood and (subsequently) tissue banking services which include the collection, processing and cryopreservation of cord blood stem cells and umbilical cord tissue. Cordlife has grown rapidly from a fledging start-up company into a multi-national corporation. In 2005, Cordlife established its first overseas cord blood processing and storage facility in Hong Kong. The ISO certified facility, with a storage capacity for 50,000 cord blood and umbilical cord units, is Hong Kong’s largest and most advanced stem cell facility. In 2011, Cordlife introduced the patented technology, CellOptima™, which is exclusively available at Cordlife in Hong Kong, to isolate two types of stem cells from umbilical cord – Epithelial stem cells and Mesenchymal Stem Cells (MSC).
Collection KitThe kit contains a closed system blood bag (brand JMS) that is pre-loaded with the anti-coagulant CPDA-1. The kit also provides the disinfectant Povidone-iodine.
Transportation ContainerThe collection kit is constructed with thermal insulation and validated to maintain room temperature for up to 48 hours during transportation back to the laboratory.
Shipping Info:Once we are informed of cord blood collection, our courier service team will pick up the kit for shipping at room temperature to the laboratory for processing and storage.
Processing MethodParents in the Philippines may have one of two processing options: The first option is to have technicians separate stem cells from the cord blood manually by the traditional method of cell sedimentation and spin. The second option is to have stem cells separated using the fully automated and closed Sepax system from Biosafe. Either way, the final component is the buffy coat layer of the blood, which holds both white cells and stem cells.
Components StoredParents are provided with a report describing test results for buffy coat holding white cells and stem cells including total nucleated cells (TNC), post processing sterility, as well as maternal blood infectious disease results.
Storage MethodFinal cord blood storage is in 25 ml blood (cryo) bag encased in an overwrap. Blood samples are kept in a quarantine freezer, then moved to long term freezer after they pass testing. Stem cells are stored in the vapour phase of cryogenic nitrogen.
Licensing & AccreditationCertified ISO 9001:2000, Registered with the Department of Health (Philippines)
Clinical ExperienceCordlife Group Limited has released 11 client cords for therapy (6 autologous, 5 allogeneic)
InsuranceClients will be covered by a program known as the Cordlife Care360 – a holistic program aimed to safeguard our client and their family.
1) Cordlife assures clients a cord blood unit of suitable match or US$25,000 to defray medical costs if the cord blood loses its viability at point of transplant.
2) Cordlife will cover the cost for additional tests required in the event of a transplant - matching (HLA resolution test) and viability assay.
3) Cordlife has taken additional insurance coverage, to safeguard client and their family from financial loss resulting from direct malpractice.
4) Cordlife provides an alternative facility at no additional cost to clients should the local facility be inaccessible.
Community ServiceFree banking (terms and conditions apply) is given to families when a sibling has a diagnosis for which transplantation is standard therapy.
Special discounts are given to medical doctors and nurses.